Gender and survival benefit from initial irinotecan in metastatic colorectal cancer: Analysis of the XELAVIRI (AIOKRK0110) study.

Authors
Publication date
1 January 2019
Publisher
'American Society of Clinical Oncology (ASCO)'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      University of Regensburg Publication Server

      redirect
      oaioai:epub.uni-regensburg.de:486...
      Last time updated on 14/10/2021